Bamco Inc Regeneron Pharmaceuticals, Inc. Transaction History

Bamco Inc

  • $36.8 Billion
  • Q3 2024

A detailed history of Bamco Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bamco Inc holds 4,500 shares of REGN stock, worth $3.41 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,500
Holding current value
$3.41 Million
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $4.61 Million - $5.41 Million
4,500 New
4,500 $4.73 Million
Q1 2018

May 09, 2018
SELL
$315.82 - $393.78 $2.11 Million - $2.63 Million
-6,673 Closed
0 $0
Q3 2017

Nov 15, 2017
BUY
$431.38 - $504.0 $2.88 Million - $3.36 Million
6,673
6,673 $2.98 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Bamco Inc Portfolio

Follow Bamco Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email